Second Sight Medical Products, Inc.
SECOND SIGHT MEDICAL PRODUCTS INC (Form: 4, Received: 03/16/2017 17:54:20)
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Cosendai Gregoire
2. Issuer Name and Ticker or Trading Symbol

SECOND SIGHT MEDICAL PRODUCTS INC [ EYES ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
VP of European Operations
(Last)          (First)          (Middle)

12744 SAN FERNANDO ROAD, SUITE 400
3. Date of Earliest Transaction (MM/DD/YYYY)

3/14/2017
(Street)

SYLMAR, CA 91342
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/14/2017   3/14/2017   A    3366   A $1.47   10395   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant to Purchase Common Stock   $1.47   3/14/2017     A      3366   (1)      3/14/2017   3/14/2022   Common Stock   3366     (1) 3366   D    
Non-Qualified Stock Option (right to buy)   $1.97                    1/3/2018   (2) 1/3/2027   Common Stock   228190     228190   D    
Non-Qualified Stock Option (right to buy)   $4.1                    1/21/2017   (2) 1/21/2026   Common Stock   11513     11513   D    
Non-Qualified Stock Option (right to buy)   $5                    11/1/2009   (3) 11/1/2018   Common Stock   20000     20000   D    
Non-Qualified Stock Option (right to buy)   $5                    2/1/2010   (3) 2/1/2019   Common Stock   5081     5081   D    
Non-Qualified Stock Option (right to buy)   $5                    5/1/2010   (3) 5/1/2019   Common Stock   10000     10000   D    
Non-Qualified Stock Option (right to buy)   $5                    2/1/2011   (3) 2/1/2020   Common Stock   14475     14475   D    
Non-Qualified Stock Option (right to buy)   $5                    6/1/2011   (3) 6/1/2020   Common Stock   2125     2125   D    
Non-Qualified Stock Option (right to buy)   $5                    12/1/2011   (4) 12/1/2020   Common Stock   25000     25000   D    
Non-Qualified Stock Option (right to buy)   $5                    3/1/2012   (4) 3/1/2021   Common Stock   6650     6650   D    
Non-Qualified Stock Option (right to buy)   $5                    3/1/2013   (4) 3/1/2022   Common Stock   7750     7750   D    
Non-Qualified Stock Option (right to buy)   $5                    4/1/2015   (4) 4/1/2024   Common Stock   10937     10937   D    
Non-Qualified Stock Option (right to buy)   $9                    9/26/2015   (4) 9/26/2024   Common Stock   51009     51009   D    
Non-Qualified Stock Option (right to buy)   $13.09                    3/26/2016   (4) 3/25/2025   Common Stock   6250     6250   D    

Explanation of Responses:
( 1)  Common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocation numbers of units were distributed on March 14, 2017.
( 2)  Options vest over a four year term of which one-fourth vest on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter.
( 3)  Options vest in 5 yearly increments starting with the Date Exercisable
( 4)  Options vest in 4 yearly increments starting with the Date Exercisable

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Cosendai Gregoire
12744 SAN FERNANDO ROAD
SUITE 400
SYLMAR, CA 91342


VP of European Operations

Signatures
/s/ Gregoire Cosendai 3/16/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.